. Variables considered include disease duration, treatment time, treatment dose, and history of relapse. Complete physical examinations and diverse complementary examinations were performed. A tumor-node-metastasis-blood staging system was applied. The population was divided into two groups according to results consisting, respectively, of those who relapsed during follow-up (n = 12) and those who did not (n = 28).